Aperio Group’s AngioDynamics ANGO Stock Holding History

Aperio Group’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$462K	Buy	30,166 +439	+1%	+$5.57K	﹤0.01%	2003
2020 Q3	$359K	Sell	29,727 -16,568	-36%	-$157K	﹤0.01%	1988
2020 Q2	$471K	Buy	46,295 +62	+0.1%	+$639	﹤0.01%	1803
2020 Q1	$482K	Buy	46,233 +30,347	+191%	+$381K	﹤0.01%	1666
2019 Q4	$254K	Buy	15,886 +4,887	+44%	+$74.6K	﹤0.01%	2117
2019 Q3	$203K	Sell	10,999 -1,516	-12%	-$29.6K	﹤0.01%	2163
2019 Q2	$246K	Sell	12,515 -1,844	-13%	-$37.6K	﹤0.01%	2097
2019 Q1	$328K	Sell	14,359 -1,978	-12%	-$42.9K	﹤0.01%	1962
2018 Q4	$329K	Buy	16,337 +3,396	+26%	+$70.3K	﹤0.01%	1898
2018 Q3	$281K	Buy	12,941 +1,248	+11%	+$27.7K	﹤0.01%	2040
2018 Q2	$260K	Buy	11,693 +566	+5%	+$11.6K	﹤0.01%	2061
2018 Q1	$192K	Buy	+11,127	New	+$186K	﹤0.01%	2151

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Aperio Group's ANGO Position: Q4 2020 in Review

Aperio Group increased its AngioDynamics (ANGO) stake by 1.5% in Q4 2020, buying an estimated $5.57K and bringing the position to 30,166 shares worth $462K. The position accounts for ﹤0.01% of the portfolio, ranked #2003.

Aperio Group first reported a position in ANGO in Q1 2018 and has held it in 12 quarters since. The position peaked at $482K in Q1 2020. 147 funds tracked by Wall St. Rank hold ANGO as of Q4 2020.

Aperio Group held 30,166 shares of AngioDynamics worth $462K as of Q4 2020.
Aperio Group bought 439 AngioDynamics shares in Q4 2020, an estimated $5.57K.
AngioDynamics made up ﹤0.01% of Aperio Group's portfolio in Q4 2020, its #2003 holding.
Aperio Group first reported a position in AngioDynamics in Q1 2018 and has held it in 12 quarters since.
Aperio Group's AngioDynamics position peaked at $482K in Q1 2020.
147 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.